Last Updated : April 19, 2023
Details
FilesGeneric Name:
brolucizumab
Project Status:
Complete
Therapeutic Area:
Diabetic macular edema
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Beovu
Project Line:
Reimbursement Review
Project Number:
SR0747-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
The treatment of diabetic macular edema (DME).
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
The treatment of diabetic macular edema (DME).
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of Canada's Drug Agency. Reimbursement criteria from Canada's Drug Agency will be documented in the final recommendation, if applicable.
| Call for patient/clinician input open | June 02, 2022 |
|---|---|
| Call for patient/clinician input closed | July 22, 2022 |
| Clarification: - Patient input submission received from Fighting Blindness Canada, The Canadian Council of the Blind, CNIB, Vision Loss Rehabilitation Canada, Diabetes Canada | |
| Submission received | June 30, 2022 |
| Submission accepted | July 15, 2022 |
| Review initiated | July 18, 2022 |
| Draft CADTH review report(s) provided to sponsor for comment | October 06, 2022 |
| Deadline for sponsors comments | October 18, 2022 |
| CADTH review report(s) and responses to comments provided to sponsor | November 11, 2022 |
| Expert committee meeting (initial) | November 23, 2022 |
| Draft recommendation issued to sponsor | December 07, 2022 |
| Draft recommendation posted for stakeholder feedback | December 15, 2022 |
| End of feedback period | January 06, 2023 |
| Final recommendation issued to sponsor and drug plans | January 18, 2023 |
| Final recommendation posted | February 08, 2023 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | February 02, 2023 |
| CADTH review report(s) posted | March 29, 2023 |
Files
Last Updated : April 19, 2023